Bupivacaine and Localised infection - a phase IV clinical study of FDA data


Localised infection is found among people who take Bupivacaine, especially for people who are male, 60+ old.

The phase IV clinical study analyzes which people take Bupivacaine and have Localised infection. It is created by eHealthMe based on reports of 11,327 people who have side effects when taking Bupivacaine from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.

On Jun, 16, 2022

11,327 people reported to have side effects when taking Bupivacaine.
Among them, 7 people (0.06%) have Localised infection.

What is Bupivacaine?

Bupivacaine has active ingredients of bupivacaine hydrochloride. eHealthMe is studying from 11,367 Bupivacaine users for its effectiveness, alternative drugs and more.

What is Localised infection?

Localised infection (infection at the single location) is found to be associated with 1,335 drugs and 810 conditions by eHealthMe.

Number of Bupivacaine and Localised infection reports submitted per year:

Could Bupivacaine cause Localised infection?

Gender of people who have Localised infection when taking Bupivacaine *:

  • female: 42.86 %
  • male: 57.14 %

Age of people who have Localised infection when taking Bupivacaine *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 14.29 %
  • 60+: 85.71 %

Common drugs people take besides Bupivacaine *:

  1. Ondansetron: 3 people, 42.86%
  2. Pantoprazole: 3 people, 42.86%
  3. Cefazolin: 3 people, 42.86%
  4. Veletri: 3 people, 42.86%
  5. Opsumit: 3 people, 42.86%
  6. Calcium: 2 people, 28.57%
  7. Lipitor: 2 people, 28.57%
  8. Androgel: 1 person, 14.29%
  9. Klor-Con M20: 1 person, 14.29%
  10. Advair Hfa: 1 person, 14.29%

Common side effects people have besides Localised infection *:

  1. Nausea (feeling of having an urge to vomit): 4 people, 57.14%
  2. Pain: 4 people, 57.14%
  3. Abdominal Pain: 3 people, 42.86%
  4. Alanine Aminotransferase Increased: 3 people, 42.86%
  5. Breathing Difficulty: 3 people, 42.86%
  6. Chest Pain: 3 people, 42.86%
  7. Diarrhea: 3 people, 42.86%
  8. Fatigue (feeling of tiredness): 3 people, 42.86%
  9. Gallbladder Disease: 3 people, 42.86%
  10. Gallstones (stone formation by bile component): 3 people, 42.86%

Common conditions people have *:

  1. Pulmonary Hypertension (increase in blood pressure in the lung artery): 2 people, 28.57%
  2. Pain: 2 people, 28.57%
  3. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 14.29%
  4. Post Laminectomy Syndrome: 1 person, 14.29%
  5. Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 1 person, 14.29%
  6. Erection Problems: 1 person, 14.29%
  7. Depression: 1 person, 14.29%
  8. Blood Testosterone Decreased: 1 person, 14.29%
  9. Apnea (temporary absence or cessation of breathing): 1 person, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Bupivacaine and have Localised infection?

Check whether Localised infection is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of Bupivacaine:

Localised infection treatments and more:

COVID vaccines that are related to Localised infection:

How severe was Localised infection and when was it recovered:

Expand to all the drugs that have ingredients of bupivacaine hydrochloride:

Common drugs associated with Localised infection:

All the drugs that are associated with Localised infection:

Common conditions associated with Localised infection:

All the conditions that are associated with Localised infection:

How the study uses the data?

The study uses data from the FDA. It is based on bupivacaine hydrochloride (the active ingredients of Bupivacaine) and Bupivacaine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: